What is he best known for?
The fields of study he is best known for:
His scientific interests lie mostly in Transfection, Gene delivery, Polyethylenimine, Molecular biology and Biochemistry.
His research integrates issues of Epidermal growth factor and Genetic transfer in his study of Transfection.
His work in Gene delivery tackles topics such as DNA which are related to areas like In vitro.
His Molecular biology research includes themes of HeLa, Gene expression and Cell biology.
His study in the field of Transferrin and Receptor-mediated endocytosis also crosses realms of Conjugate.
His Biophysics research incorporates themes from Polylysine and Polyethylene glycol.
His most cited work include:
- PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery (1027 citations)
- The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. (508 citations)
- Polylysine-based transfection systems utilizing receptor-mediated delivery. (479 citations)
What are the main themes of his work throughout his whole career to date?
Transfection, Gene delivery, Molecular biology, Polyethylenimine and Cancer research are his primary areas of study.
His Transfection study is concerned with the larger field of Biochemistry.
His research investigates the connection between Gene delivery and topics such as Stereochemistry that intersect with issues in Biocompatibility.
His study in Molecular biology is interdisciplinary in nature, drawing from both Reporter gene, Gene expression, Transgene, Receptor and Cell biology.
Manfred Ogris interconnects Size-exclusion chromatography, HeLa, Polyethylene glycol, PEGylation and Zeta potential in the investigation of issues within Polyethylenimine.
His biological study spans a wide range of topics, including Cancer, Targeted therapy, Genetic enhancement and Pathology.
He most often published in these fields:
- Transfection (32.24%)
- Gene delivery (33.55%)
- Molecular biology (30.26%)
What were the highlights of his more recent work (between 2015-2021)?
- Nucleic acid (15.13%)
- Cancer research (22.37%)
- Gene delivery (33.55%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Nucleic acid, Cancer research, Gene delivery, In vitro and Luciferase.
His work deals with themes such as Internalization and Genetic enhancement, which intersect with Cancer research.
His In vitro research is classified as research in Biochemistry.
His Luciferase study improves the overall literature in Transfection.
His work carried out in the field of Transfection brings together such families of science as Transferrin, Receptor, Epidermal growth factor, HeLa and Flow cytometry.
His Molecular biology study incorporates themes from Polyethylenimine and Peptide.
Between 2015 and 2021, his most popular works were:
- Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis (57 citations)
- Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet Formation. (28 citations)
- Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene (18 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Biodistribution, Gene delivery, Sodium-iodide symporter, Genetic enhancement and Cancer research.
His Biodistribution research is multidisciplinary, incorporating perspectives in Radionuclide therapy, Molecular biology, Transduction, Receptor expression and PLGA.
Manfred Ogris integrates many fields, such as Gene delivery and Pancreatic ductal adenocarcinoma, in his works.
In his articles, Manfred Ogris combines various disciplines, including Sodium-iodide symporter and Cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
